Literature DB >> 956451

Effect of methotrexate therapy in psoriatics on the Ito cells in liver biopsies, assessed by point-counting.

D Hopwood, A Nyfors.   

Abstract

To evaluate the relationship, both quantitative and qualitative, between the Ito cells and methotrexate (MTX) therapy Ito cells were studied by light microscopy in 1 mum toluidine blue stained sections and by electron microscopy in 24 pairs of Menghini needle biopsies before and after MTX therapy of 24 consenting patients with severe psoriasis. Light microscopy showed a statistically significant increase in pathological findings (P less than 0-05) and in the number of Ito cells and their size (P less than 0-0001) after MTX therapy. It was not possible to show a statistically significant correlation between the increase in the number of Ito cells and the cumulative dose of MTX. Ultrastructural analysis of Ito cells showed no marked difference from pre to post-MTX specimens. The fibrosis and cirrhosis seen after MTX therapy in some liver biopsies from psoriatics and the post-MTX increase in the number of Ito cells direct attention to the possible role of Ito cells as fibroblast precursors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956451      PMCID: PMC476149          DOI: 10.1136/jcp.29.8.698

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  [Morphological studies of the fat storage cells of the liver in various vertebrates. I. Fat storage cells of hoofed animals].

Authors:  T ITO; M NEMOTO
Journal:  Okajimas Folia Anat Jpn       Date:  1956-09

2.  The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver injury.

Authors:  J O McGee; R S Patrick
Journal:  Lab Invest       Date:  1972-04       Impact factor: 5.662

3.  Liver ultrastructure in methotrexate treatment of psoriasis.

Authors:  E Horvath; K Kovacs; R C Ross
Journal:  Arch Dermatol       Date:  1973-09

4.  Psoriasis-liver-methotrexate interactions.

Authors: 
Journal:  Arch Dermatol       Date:  1973-07

5.  Cirrhosis caused by methotrexate in the treatment of psoriasis.

Authors:  S A Muller; G M Farrow; D L Martalock
Journal:  Arch Dermatol       Date:  1969-11

6.  Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy.

Authors:  A Nyfors; H Brodthagen
Journal:  Dermatologica       Date:  1970

7.  Methotrexate for psoriasis in weekly oral doses.

Authors:  H H Roenigk; W Fowler-Bergfeld; G H Curtis
Journal:  Arch Dermatol       Date:  1969-01

8.  Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients.

Authors:  A Nyfors; H Poulsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-05

9.  Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.

Authors:  A Nyfors; H Poulsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-05

10.  The fine structural localization of endogenous and exogenous peroxidase activity in Kupffer cells of rat liver.

Authors:  H D Fahimi
Journal:  J Cell Biol       Date:  1970-10       Impact factor: 10.539

View more
  8 in total

1.  Desmosomal abnormalities in the liver of methotrexate-treated psoriatics.

Authors:  E Horvath; K Kovacs; R C Ross; F Saibil; N A Kerenyi
Journal:  Experientia       Date:  1977-09-15

2.  Collagen metabolism in the liver. An annotated and supplemented report of a workshop at the National Institutes of Health on February 28 and March 1, 1977.

Authors: 
Journal:  Am J Dig Dis       Date:  1978-07

3.  Effect of gallstone-dissolution therapy on human liver structure.

Authors:  M C Bateson; D Hopwood; I A Bouchier
Journal:  Am J Dig Dis       Date:  1977-04

Review 4.  The hepatic stellate (Ito) cell: its role in human liver disease.

Authors:  M L Hautekeete; A Geerts
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

5.  Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.

Authors:  P D Hall; M J Ahern; L R Jarvis; P Stoll; M A Jenner; H Harley
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

6.  Healing of focal injury in the rat liver.

Authors:  K Ogawa; J Suzuki; M Narasaki; M Mori
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

7.  Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome.

Authors:  A S Leong; M H Alp
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

8.  Metformin ameliorates methotrexate-induced hepatotoxicity.

Authors:  Najah R Hadi; Fadhil G Al-Amran; Asma Swadi
Journal:  J Pharmacol Pharmacother       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.